By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


3SBio Inc. 

3 A1, Road 10
Economy & Technology Development Zone
Shenyang    110027  China
Phone: 86-24-2581-1820 Fax:


Company News
3SBio (SSRX) Acquires CDMO Business From Canada's Therapure For $290 Million 9/5/2017 1:21:24 PM
3SBio (SSRX) Pays $290 Million For Therapure's CDMO Biz 9/5/2017 6:38:21 AM
3SBio (SSRX) Will Market Eli Lilly (LLY)'s Recombinant Insulin In China 5/18/2017 2:14:03 PM
3SBio (SSRX) Appoints Dr. Zhenping Zhu As President Of Research & Development And Chief Scientific Officer 1/9/2017 7:46:20 AM
3SBio (SSRX) Pays $100 Million To Market Two AstraZeneca PLC (AZN) Diabetes Drugs In China 10/12/2016 10:42:22 AM
3SBio Inc. (SSRX) And Sorrento (SRNE) Form $10 Million China JV For CAR-T Drugs 6/7/2016 2:47:43 PM
Sorrento (SRNE) And 3SBio Inc. (SSRX) Announce CAR-T Joint Venture In China 6/7/2016 12:00:24 PM
3SBio Inc. (SSRX) Selected As A Constituent Of The MSCI China Index 5/13/2016 7:54:07 AM
3SBio Inc. (SSRX) Approved For Trials Of PEG-Irinotecan 3/8/2016 9:35:02 AM
3SBio Inc. (SSRX)'s PEG-irinotecan Wins IND Approval From China FDA 3/7/2016 7:26:03 AM